Cargando…

National long COVID impact and risk factors

OBJECTIVE: Our objective was to estimate the prevalence and risk factors for long COVID symptoms among polymerase chain reaction–confirmed COVID-19 patients (hospitalised and community) in Malta. STUDY DESIGN: This was a national cross-sectional survey among COVID-19 patients in Malta during 2020. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Baruch, J., Zahra, C., Cardona, T., Melillo, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society for Public Health. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683693/
https://www.ncbi.nlm.nih.gov/pubmed/36434908
http://dx.doi.org/10.1016/j.puhe.2022.09.021
_version_ 1784835109288935424
author Baruch, J.
Zahra, C.
Cardona, T.
Melillo, T.
author_facet Baruch, J.
Zahra, C.
Cardona, T.
Melillo, T.
author_sort Baruch, J.
collection PubMed
description OBJECTIVE: Our objective was to estimate the prevalence and risk factors for long COVID symptoms among polymerase chain reaction–confirmed COVID-19 patients (hospitalised and community) in Malta. STUDY DESIGN: This was a national cross-sectional survey among COVID-19 patients in Malta during 2020. METHODS: Patients were sent a questionnaire 3–6 months after testing positive. Data were analysed descriptively to estimate symptom prevalence, and multivariable logistic regressions were used to determine the risk factors for long COVID symptoms. Age, sex, initial symptoms, hospitalisation, and healthcare worker status were used as risk factors and symptoms (cough, shortness of breath, fatigue, anxiety, sadness, and memory loss) 2.5 months or more after COVID-19 onset were used as outcomes. RESULTS: Of 8446 eligible participants, 2665 (31.55%) responded with a median age of 37 years. Initial symptoms were reported in 82% of responders, and 7.73% were hospitalised. Among the long COVID symptoms, fatigue persisted among most non-hospitalised responders, whereas anxiety, shortness of breath, and sadness were the most common symptoms. Female sex, hospitalisation, and initial symptoms were associated with higher odds of fatigue, shortness of breath, cough, anxiety, sadness, and memory loss as long COVID symptoms. CONCLUSIONS: Our study is the first to highlight long COVID symptoms and risk factors in Malta, showing that long COVID is common among hospitalised and non-hospitalised patients. These data should increase awareness of long COVID and facilitate support to those affected nationally.
format Online
Article
Text
id pubmed-9683693
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society for Public Health. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-96836932022-11-25 National long COVID impact and risk factors Baruch, J. Zahra, C. Cardona, T. Melillo, T. Public Health Original Research OBJECTIVE: Our objective was to estimate the prevalence and risk factors for long COVID symptoms among polymerase chain reaction–confirmed COVID-19 patients (hospitalised and community) in Malta. STUDY DESIGN: This was a national cross-sectional survey among COVID-19 patients in Malta during 2020. METHODS: Patients were sent a questionnaire 3–6 months after testing positive. Data were analysed descriptively to estimate symptom prevalence, and multivariable logistic regressions were used to determine the risk factors for long COVID symptoms. Age, sex, initial symptoms, hospitalisation, and healthcare worker status were used as risk factors and symptoms (cough, shortness of breath, fatigue, anxiety, sadness, and memory loss) 2.5 months or more after COVID-19 onset were used as outcomes. RESULTS: Of 8446 eligible participants, 2665 (31.55%) responded with a median age of 37 years. Initial symptoms were reported in 82% of responders, and 7.73% were hospitalised. Among the long COVID symptoms, fatigue persisted among most non-hospitalised responders, whereas anxiety, shortness of breath, and sadness were the most common symptoms. Female sex, hospitalisation, and initial symptoms were associated with higher odds of fatigue, shortness of breath, cough, anxiety, sadness, and memory loss as long COVID symptoms. CONCLUSIONS: Our study is the first to highlight long COVID symptoms and risk factors in Malta, showing that long COVID is common among hospitalised and non-hospitalised patients. These data should increase awareness of long COVID and facilitate support to those affected nationally. The Royal Society for Public Health. Published by Elsevier Ltd. 2022-12 2022-11-23 /pmc/articles/PMC9683693/ /pubmed/36434908 http://dx.doi.org/10.1016/j.puhe.2022.09.021 Text en © 2022 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Research
Baruch, J.
Zahra, C.
Cardona, T.
Melillo, T.
National long COVID impact and risk factors
title National long COVID impact and risk factors
title_full National long COVID impact and risk factors
title_fullStr National long COVID impact and risk factors
title_full_unstemmed National long COVID impact and risk factors
title_short National long COVID impact and risk factors
title_sort national long covid impact and risk factors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683693/
https://www.ncbi.nlm.nih.gov/pubmed/36434908
http://dx.doi.org/10.1016/j.puhe.2022.09.021
work_keys_str_mv AT baruchj nationallongcovidimpactandriskfactors
AT zahrac nationallongcovidimpactandriskfactors
AT cardonat nationallongcovidimpactandriskfactors
AT melillot nationallongcovidimpactandriskfactors